Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.

Shiau S, Strehlau R, Technau KG, Patel F, Arpadi SM, Coovadia A, Abrams EJ, Kuhn L.

AIDS. 2017 Jan 28;31(3):355-364. doi: 10.1097/QAD.0000000000001312.

PMID:
27828785
2.

Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.

Chiu A, Modi S, Rivadeneira ED, Koumans EH.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):454-462.

3.

Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain.

Rokx C, Richman DD, Müller-Trutwin M, Silvestri G, Lunzen J, Khoo S, Lichterfeld M, Altfeld M, Perno CF, Hunt PW, Mallon P, Rockstroh JK, Pozniak AL, Clotet B, Boucher CA.

J Virus Erad. 2015 Jul 1;1(3):211-20.

4.

Host factors and early treatments to restrict paediatric HIV infection and early disease progression.

Gianesin K, Petrara R, Freguja R, Zanchetta M, Giaquinto C, De Rossi A.

J Virus Erad. 2015 Jul 1;1(3):140-7. Review.

5.

[Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].

Soubeiga ST, Compaore R, Djigma F, Zagre N, Assengone E, Traore L, Diarra B, Bisseye C, Ouermi D, Sagna T, Karou S, Pietra V, Simpore J.

Pan Afr Med J. 2015 Apr 23;20:399. doi: 10.11604/pamj.2015.20.399.5627. eCollection 2015. French. No abstract available.

6.

Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil.

Moreira-Silva SF, Zandonade E, Miranda AE.

BMC Infect Dis. 2015 Mar 25;15:155. doi: 10.1186/s12879-015-0893-0.

7.

Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.

Chohan BH, Tapia K, Benki-Nugent S, Khasimwa B, Ngayo M, Maleche-Obimbo E, Wamalwa D, Overbaugh J, John-Stewart G.

AIDS Res Hum Retroviruses. 2015 Aug;31(8):783-91. doi: 10.1089/AID.2014.0370. Epub 2015 Apr 22.

8.

Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection.

Lazarus JR, Rutstein RM, Lowenthal ED.

HIV Med. 2015 Jul;16(6):355-61. doi: 10.1111/hiv.12220. Epub 2015 Jan 21.

9.

Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi baby.

Shiau S, Kuhn L.

Expert Rev Anti Infect Ther. 2014 Mar;12(3):307-18. doi: 10.1586/14787210.2014.888311. Epub 2014 Feb 9. Review.

10.

Mother-to-child transmission of HIV: findings from an early infant diagnosis program in Bertoua, Eastern Cameroon.

Noubiap JJ, Bongoe A, Demanou SA.

Pan Afr Med J. 2013 Jun 21;15:65. doi: 10.11604/pamj.2013.15.65.2551. eCollection 2013.

11.

Immunology of pediatric HIV infection.

Tobin NH, Aldrovandi GM.

Immunol Rev. 2013 Jul;254(1):143-69. doi: 10.1111/imr.12074. Review.

12.

Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women.

Kim HY, Kasonde P, Mwiya M, Thea DM, Kankasa C, Sinkala M, Aldrovandi G, Kuhn L.

BMC Pediatr. 2012 Aug 31;12:138. doi: 10.1186/1471-2431-12-138.

13.

Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).

Kapogiannis BG, Soe MM, Nesheim SR, Abrams EJ, Carter RJ, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Clin Infect Dis. 2011 Nov;53(10):1024-34. doi: 10.1093/cid/cir641.

14.

Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.

Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.

AIDS. 2011 Nov 28;25(18):2279-87. doi: 10.1097/QAD.0b013e32834d614c.

15.

Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon.

Tejiokem MC, Faye A, Penda IC, Guemkam G, Ateba Ndongo F, Chewa G, Rekacewicz C, Rousset D, Kfutwah A, Boisier P, Warszawski J; ARNS 12140-PEDIACAM study group.

PLoS One. 2011;6(7):e21840. doi: 10.1371/journal.pone.0021840. Epub 2011 Jul 19.

16.

Induction maintenance concept for HAART as initial treatment in HIV infected infants.

Ghosh S, Neubert J, Niehues T, Adams O, Morali-Karzei N, Borkhardt A, Laws HJ.

Eur J Med Res. 2011 Jun 21;16(6):243-8.

17.

Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007.

Ramos AN Jr, Matida LH, Hearst N, Heukelbach J.

AIDS Res Ther. 2011 Jul 18;8:23. doi: 10.1186/1742-6405-8-23.

18.

Asking the right questions: developing evidence-based strategies for treating HIV in women and children.

Karim QA, Banegura A, Cahn P, Christie CD, Dintruff R, Distel M, Hankins C, Hellmann N, Katabira E, Lehrman S, Montaner J, Purdon S, Rooney JF, Wood R, Heidari S.

BMC Public Health. 2011 May 25;11:388. doi: 10.1186/1471-2458-11-388.

19.

Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A.

Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20.

20.

Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression?

Hainaut M, Verscheure V, Ducarme M, Schandené L, Levy J, Mascart F.

Clin Exp Immunol. 2011 Jul;165(1):77-84. doi: 10.1111/j.1365-2249.2011.04403.x. Epub 2011 Apr 19.

Supplemental Content

Support Center